Wolverine Asset Management’s Sanofi SNY Stock Holding History

Wolverine Asset Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-150	Closed	-$19K	–	2000
2015 Q1	$19K	Hold	150	–	–	﹤0.01%	1458
2014 Q4	$16K	Buy	+150	New	+$7.28K	﹤0.01%	1670
2014 Q3	–	Sell	-28	Closed	-$2K	–	2653
2014 Q2	$2K	Buy	+28	New	+$1.49K	﹤0.01%	2183

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wolverine Asset Management's SNY Position: Q1 2015 in Review

Wolverine Asset Management sold out of Sanofi (SNY) in Q1 2015, closing a stake of 700 shares — an estimated $33.5K sold.

Wolverine Asset Management first reported a position in SNY in Q1 2014 and held it in 4 quarters. The position peaked at $203K in Q3 2014. 517 funds tracked by Wall St. Rank hold SNY as of Q1 2015.

Wolverine Asset Management reported no remaining Sanofi position as of Q1 2015 after selling out during the quarter.
Wolverine Asset Management sold 700 Sanofi shares in Q1 2015, an estimated $33.5K.
Wolverine Asset Management first reported a position in Sanofi in Q1 2014 and held it in 4 quarters.
Wolverine Asset Management's Sanofi position peaked at $203K in Q3 2014.
517 funds tracked by Wall St. Rank held Sanofi as of Q1 2015.

Based on Wolverine Asset Management's 13F filing for Q1 2015, filed 15 May 2015.